Raven Delta Innovations brings together applied environmental science, intelligent sensing, AI analytics, exposure assessment and real‑world deployment to help partners solve complex health, environmental and operational challenges. We are the applied R&D arm of the Raven Delta Group, working alongside the NHS, government and industry.
We are a technical applied science and engineering capability. Every programme is led by hands-on expertise in environmental monitoring, sensor instrumentation, data pipelines, exposure analysis and AI-enabled modelling, with deployment delivered through the Raven Delta Group operating companies.
Every programme begins with a defined operational, environmental, health or commercial problem owned by an external partner. We do not pursue research in the abstract.
In-house capability in monitoring design, instrumentation, data analysis, modelling and evidence translation. We do the technical work, we do not subcontract it.
Methodologies drawn from the academic literature or government guidelines and validated using recognised instruments. Outputs designed to stand up to peer review, regulatory scrutiny and procurement.
Through the Raven Delta Group operating companies, every validated solution has a route to deployment in real buildings, real estates and real care pathways, at scale.
There is no shortage of research, technology or capital in the UK innovation system. What is missing is the connective tissue. The capability to take a real problem and route it through the right academic group, the right technology partner and the right funding stream, all the way to a solution that operates in the field.
Yet a small fraction reaches operational deployment in the public sector or regulated industry.
Do not progress beyond initial evaluation. Strong evidence and clear implementation pathways are what move research into adoption.
From research finding to clinical or operational deployment. We aim to compress this materially.
Indicative figures drawn from UKRI annual reports and NHS England innovation evaluation summaries. Used to characterise the translation gap that Raven Delta Innovations is structured to address.
Beyond coordinating partnerships and funding, we are a hands-on technical capability. Our specialists work directly on instrumentation, data acquisition, analysis, modelling and evidence translation. This is what allows us to take a problem from a brief to a deployed, validated solution.
Design and deployment of indoor and outdoor monitoring programmes covering PM2.5, PM10, NO2, CO2, VOCs, temperature, humidity and other parameters relevant to indoor environmental quality and building performance.
Selection, deployment and management of sensor arrays. We integrate fixed, portable and personal monitoring devices into a unified data pipeline, with field validation against reference-grade instruments.
Live data acquisition from instrumented environments, integrated into resilient data pipelines for storage, quality control, processing and visualisation. Continuous monitoring rather than one-off snapshots.
Integrated personal exposure assessment using time-activity modelling, microenvironment stratification and individual exposure profiles measured against WHO Air Quality Guidelines and relevant occupational standards.
Statistical and machine learning models applied to environmental, behavioural and clinical data. Health impact analysis, predictive maintenance, anomaly detection and decision-support tools for operational teams.
Translation of field data into peer-reviewable outputs, regulatory submissions, procurement evidence packages and contribution to emerging standards such as BS40102 for indoor environmental quality.
Every programme moves through the same five stages. The stages are deliberately structured so that academic rigour, technology selection, funding alignment and operational delivery are addressed in sequence, with clear gates between each. Timescales vary considerably by project type and scope.
We work with the problem owner to characterise the operational, clinical or commercial issue. We define success criteria, identify stakeholders and produce a research brief.
We review the relevant academic and technical literature, identify candidate methodologies and technologies, and design a solution architecture grounded in the evidence base.
We map the proposition against available funding routes (research grants, innovation calls, ICB budgets, private co-investment) and convene the right academic and industry partners.
The solution is deployed in a real operational environment under a defined study protocol. Outcomes are measured using validated instruments and audited against the original success criteria.
Validated solutions are scaled through the Raven Delta Group operating companies, supported by the evidence base generated during the field study. IP is structured for reuse across estates.
The technical and programme functions we offer across the lifecycle of a research programme, from initial scoping through to scaled deployment. Each programme draws on the combination required by the problem.
Definition of the research question, study protocol, sampling strategy and instrumentation plan. Selection of validated outcome measures and statistical approach upfront.
Hands-on installation, commissioning and ongoing management of monitoring equipment. Field validation against reference instruments and traceable records.
End-to-end data flow from instrument to analyst. Storage, QA/QC, processing and operational dashboards for partner teams, with live exposure and risk indicators where relevant.
Statistical analysis, exposure modelling, health impact analysis and AI-enabled prediction. Translation of complex datasets into interpretable findings and decision support.
Outputs designed for the intended audience. Peer-reviewable papers for academic partners, procurement evidence for operational teams, regulatory submissions and standards contribution where relevant.
Operational roll-out into real buildings, estates and care pathways through the Raven Delta Group operating companies. Ongoing measurement, iteration and a clear route to commercial scale.
Two examples of the methodology applied end to end. A paediatric asthma case where indoor air quality was managed in the home environment, and a real-world pilot across five commercial kitchens in Westminster testing source-level air purification as a route to reducing PM2.5 pollution. Outcomes in both cases were independently measured against recognised standards.
A paediatric asthma patient's home was instrumented for continuous indoor PM2.5 monitoring. A Medicair air purifier was deployed and operated over a three-month intervention, maintaining sustained indoor PM2.5 below the WHO Air Quality Guideline of 5 µg/m³. Clinical outcomes validated by SGRQ and EQ-5D-3L; participant became symptom-free and medication was discontinued under clinical supervision.
Westminster City Council commissioned a real-world pilot across five contrasting commercial kitchens to test whether source-level air purification could reduce indoor PM2.5 without disrupting service. Baseline and intervention phases of roughly six weeks each were compared across April to November 2025. All five sites recorded lower hourly PM2.5 means during the intervention phase.
Percentage reductions are relative to indoor PM2.5 hourly means during matched baseline and intervention phases at each site. Performance varies with kitchen size, airflow and cooking pattern. Disclosure: Raven Delta Group acquired Medicair Ltd, manufacturer of the Medicair Pro units used in this pilot, in April 2025 while the project was already underway.
Raven Delta Innovations is a distinct organisation in a crowded landscape. Understanding how we differ from adjacent organisations is the fastest way to identify whether we are the right partner for your programme.
We work with problem owners, research groups, technology vendors and capital providers under a single coordinating structure. The role of Raven Delta Innovations is to assemble the right combination for each programme and hold it together through to deployment.
NHS innovation teams, health boards, Integrated Care Boards and clinical leads bringing forward patient outcome, demand pressure and environmental health challenges.
Welsh Government, UK departments and frameworks defining the operating environment, including the New Hospital Programme, housing standards and environmental health policy.
Universities, clinical research groups and standards bodies. We co-design research programmes that generate peer-reviewable evidence and contribute to standards such as BS40102.
Sensor manufacturers, med-tech companies, AI vendors and product engineers. We evaluate and integrate technologies against defined real-world outcome targets.
Housing providers, estates and facilities teams responsible for the buildings where people live, work and receive care. The operational environment where our research is deployed.
Research councils, Innovate UK, ICB budgets, philanthropic foundations and private co-investors. Blended funding aligned to the technical and operational stages of each programme.
NHS, government, industry or academic. We respond to every enquiry within five working days. The first conversation is usually a 30-minute call to understand whether your problem is a fit for our programme.
